No Data
No Data
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Express News | FDA Adds Boxed Warning About Anaphylaxis With Multiple Sclerosis Medicine Glatiramer Acetate (Copaxone, Glatopa)
Google Parent-Owned Startup To Launch AI-Designed Drug Trials By Year-End, Partnering With Eli Lilly And Novartis To Tackle Major Diseases
The speed of drug research and development has increased by ten times! Google states that the first AI-designed medication will enter testing by the end of the year.
Demis Hassabis, the founder of Google's drug development company, stated that traditional drug development usually takes 5 to 10 years, while with the help of AI technology, this process may be accelerated by 10 times. Former USA Treasury Secretary Summers once commented that AI's relationship with the Internet Plus-Related is similar to that of computers with calculators.
Top Gap Ups and Downs on Tuesday: TEM, MMM, DJT and More
Novartis (NVS.US) CEO: The market's concerns over Trump's pharmaceutical policy are overly exaggerated.
Narasinghan stated that the new health policy may be helpful to pharmaceutical companies; the company is looking to reverse some measures of the previous government.
JimyJimy : can we run this up today
the MONEY drifter ♂ : lot of good news with this candidate. It's already on my watchlist today
Stock_Drift OP JimyJimy : Let’s hope so!!